Silo Pharma’s QwikAgents Expands AI Agent Platform with NVIDIA Model Support and New Runtime Flexibility
Key Highlights
- ➤QwikAgents adds NVIDIA Nemotron model support through customer-supplied API keys
- ➤Hermes runtime joins OpenClaw, giving customers a second agent software option
- ➤NVIDIA becomes QwikAgents’ fifth supported bring-your-own-key provider
- ➤New capabilities are available now across QwikAgents’ managed AI agent platform
Expert Statements
Eric Weisblum, Chief Executive Officer of Silo Pharma
“AI models and agent software are both evolving rapidly, and we believe customers should have the flexibility to choose the technologies that best fit their needs rather than be locked into a single provider or runtime.”
Eric Weisblum, Chief Executive Officer of Silo Pharma
“By adding NVIDIA model support and a second agent runtime, we are expanding QwikAgents as a flexible platform that can evolve with the AI ecosystem while providing customers with a consistent managed infrastructure.”
Eric Weisblum, Chief Executive Officer of Silo Pharma
“We expect to continue broadening the models and runtimes available through the platform over time.”
Addition of NVIDIA Nemotron models and Hermes runtime expands customer choice across both AI models and agent software
SARASOTA, FLA., Sept. 30, 2026 (GLOBE NEWSWIRE) -- Silo Pharma (Nasdaq: SILO) (“Silo” or “the Company”), a developmental-stage biopharmaceutical company focused on novel therapeutics and drug delivery systems with a wholly owned managed AI agent subsidiary QwikAgents, today announced that QwikAgents has expanded its AI agent platform with new customer choice across both AI models and agent software, including support for customer-supplied NVIDIA API keys and the addition of Hermes agent runtime. The new capabilities are available now and are designed to provide customers greater flexibility in how their AI agents are configured and operated.
Get started
Create a free account to read the full story.